Neuroview Technology is a data-driven technology platform and medical device company specializing in neurology outcomes. Our mission is to provide enduring solutions that enhance the quality of life, improve clinical management, and reduce the cost of patient care. Our breakthrough device is an implantable subcutaneous long-term Brain monitor using EEG, making it the first long-term, minimally invasive device of its kind approved by the FDA.

Traditional EEG studies are limited to a few days, providing limited information on dynamic brain disorders. However, our technology accurately identifies unrecognized seizures, prevents false characterization of events, and provides valuable information for optimized management. By employing AI and ML to analyze long-term EEG data, we aim to personalize care, improve outcomes, reduce costs, and predict outcomes.

With real-time data and analytics available to both patients and physicians, Neuroview Technology represents a revolutionary paradigm shift in brain monitoring and the treatment of epilepsy and other neurologic disorders